1. Home
  2. AVTX vs WPRT Comparison

AVTX vs WPRT Comparison

Compare AVTX & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • WPRT
  • Stock Information
  • Founded
  • AVTX 2011
  • WPRT 1995
  • Country
  • AVTX United States
  • WPRT Canada
  • Employees
  • AVTX N/A
  • WPRT N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • WPRT Industrial Machinery/Components
  • Sector
  • AVTX Health Care
  • WPRT Industrials
  • Exchange
  • AVTX Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • AVTX 90.9M
  • WPRT 78.4M
  • IPO Year
  • AVTX 2015
  • WPRT 1995
  • Fundamental
  • Price
  • AVTX $10.13
  • WPRT $4.43
  • Analyst Decision
  • AVTX Buy
  • WPRT Buy
  • Analyst Count
  • AVTX 2
  • WPRT 3
  • Target Price
  • AVTX $35.00
  • WPRT $16.33
  • AVG Volume (30 Days)
  • AVTX 59.3K
  • WPRT 77.0K
  • Earning Date
  • AVTX 11-07-2024
  • WPRT 11-12-2024
  • Dividend Yield
  • AVTX N/A
  • WPRT N/A
  • EPS Growth
  • AVTX N/A
  • WPRT N/A
  • EPS
  • AVTX N/A
  • WPRT N/A
  • Revenue
  • AVTX $820,000.00
  • WPRT $314,357,000.00
  • Revenue This Year
  • AVTX N/A
  • WPRT N/A
  • Revenue Next Year
  • AVTX N/A
  • WPRT N/A
  • P/E Ratio
  • AVTX N/A
  • WPRT N/A
  • Revenue Growth
  • AVTX N/A
  • WPRT 2.86
  • 52 Week Low
  • AVTX $3.95
  • WPRT $3.91
  • 52 Week High
  • AVTX $34.46
  • WPRT $7.86
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 37.71
  • WPRT 57.97
  • Support Level
  • AVTX $12.00
  • WPRT $4.21
  • Resistance Level
  • AVTX $13.59
  • WPRT $4.48
  • Average True Range (ATR)
  • AVTX 0.96
  • WPRT 0.19
  • MACD
  • AVTX -0.50
  • WPRT 0.06
  • Stochastic Oscillator
  • AVTX 17.42
  • WPRT 88.14

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing, and capital allocation.

Share on Social Networks: